FDA warns Allergan on Aczone promotion

Washington ?An advertisement for Aczone (Allergan), a gel used to treat mild-to-moderate acne, “grossly overstates” the drug?s effectiveness, the Food and Drug Administration (FDA) stated in a letter released Aug. 21

View original post here:
FDA warns Allergan on Aczone promotion

Related posts:

1. FDA: Allergan Aczone ads were misleading The U.S. Food and Drug Administration on Friday released a...
2. FDA Sends Letter to Sanofi Aventis Regarding Promotion for BenzaClin ROCKVILLE, Md., Feb. ...
3. FDA Warns Five E-Cigarette Companies The Food and Drug Administration (FDA) has issued a marketing...
4. Biovail buys Canada rights to Aczone Biovail Laboratories, a subsidiary of Valeant Pharmaceuticals International, based here,...
5. Party Drug Dependence Higher Among Gay Men, Expert Warns, UK In 2009, in response to patients experiencing severe withdrawal reactions...

Leave a comment

Name (required)

E-mail (required)

URI

Your Message